Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

Clinical trial NCT03325166 · TERMINATED

Trial details

NCT number: NCT03325166
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Carcinoma Metastatic in the Brain Stage IV Lung Non-Small Cell Cancer AJCC v7

Start date: 2017-11-03
Primary completion: 2021-03-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.